U.S.-LISTED SHARES OF REDHILL BIOPHARMA RISE 2.4% ON ADDITIONAL FUNDING FOR MID-STAGE STUDY OF COVID DRUG
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.433 USD | +1.17% | -2.12% | -70.34% |
1st Jan change | Capi. | |
---|---|---|
-70.34% | 13.64M | |
-4.06% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-7.02% | 8.12B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- U.s.-Listed Shares Of Redhill Biopharma Rise 2.4% On Additional…